News & Insights

Effective digital healthcare management ensures patient safety and accessibility. By prioritising patient-centric approaches and leveraging advanced technologies, healthcare organisations can optimise inventory management, reduce administrative burdens, and improve efficiency.

Zuellig Pharma is strengthening across all facets, building a resilient cross-regional supply chain, improving regional infrastructure, and sharing data and knowledge across markets, by leveraging technology and investing in sustainable practices.

Zuellig Pharma over the past four years, has ranked within the top 1% of organisations worldwide, recognised for its performance in environmental efforts, labour and human rights, ethics and sustainable procurement.

With the global healthcare industry now responsible for 5 per cent of carbon emissions, more needs to be done to minimise waste especially in light of Asia's ageing population and increasing climate risks jeopardising health.

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc. to launch and commercialise Libtayo (cemiplimab), a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells, in South Korea and Taiwan.

Interpharma Investments Limited, the holding company of leading healthcare solutions provider Zuellig Pharma, today announced the appointment of Dr. Christiane Hamacher as a new member of its Board of Directors.